We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines. Objective: To examine ...
Risk of arterial (ATE) and venous thromboembolism (VTE) in a population-based cohort of bevacizumab-treated metastatic colorectal cancer (mCRC) patients. Sustainability of antiemetic responses with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback